CVS Health launched Clinical Trial Services (CTS) in mid-2021, with the aim of expanding clinical trial participation in previously underserved demographics, because a CVS retail location is no more than 10 miles from the majority of the American population. Dr. Owen Garrick, MD, Chief Medical Officer at CTS, discusses how the accessibility and flexibility of this decentralized model can address issues of diverse participation in clinical trials.
Owen Garrick, MD, is the Chief Medical Officer for Clinical Trial Services at CVS Health. He joined in April 2021. Prior to joining CVS Health, Dr Garrick was President of Bridge Clinical Research, where he had responsibility for the Clinical Trials, Research Analytics, Health Services Research and Healthcare Communications business units. While at Bridge Clinical he helped launch multiple collaborative efforts in advancing precision medicine research and data science. His study “Does Diversity Matter for Health? Experimental Evidence from Oakland” won the 2021 Research Paper of the Year by the American Society of Health Economists. Prior to joining Bridge Clinical, Dr Garrick was Director of Strategy and Business Development at McKesson Corporation. Before joining McKesson, Dr Garrick was Global Head of M&A Negotiations at Novartis Pharmaceuticals.
Dr Garrick is a nationally recognized leader in the field of research and research ethics. He was confirmed and completed a term with the Department of Health and Human Services Advisory Council on Human Research Protections from 2012-2016. He has co-authored industry advisory documents around biospecimen data security and patient engagement in research and currently serves on the board of Professional Responsibility in Medicine & Research (PRIMR). Dr Garrick earned his MD from Yale School of Medicine and his MBA from Wharton School of Business. He holds an AB in Psychology from Princeton University.